Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation
Status:
Active, not recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether 3 cycles of chemotherapy(CEV) are as
effective as 6 cycles of chemotherapy(CEV) in the treatment of Stage I enucleated
retinoblastoma.